Skip to main content

More Filters

1,077 results

Showing: 21 - 40 of 1077 results
  1. pAAV-hSyn-DIO-hM4D(Gi)-mCherry (AAV5)

    Viral Prep
    #44362-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-hSyn-DIO-hM4D(Gi)-mCherry (#44362). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-hM4D(Gi)-mCherry plasmid DNA. Syn-driven, Cre-dependent hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal silencing. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCherry (Cre-dependent)
    Available Since
    Dec. 1, 2016
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (AAV5)

    Viral Prep
    #20298-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (#20298). In addition to the viral particles, you will also receive purified pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA plasmid DNA. EF1a-driven, Cre-dependent, humanized channelrhodopsin H134R mutant fused to EYFP, for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    EYFP (Cre-dependent)
    Available Since
    Feb. 15, 2018
    Availability
    Academic Institutions and Nonprofits only
  3. pENN.AAV.hSyn.Cre.WPRE.hGH (AAV9)

    Viral Prep
    #105553-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pENN.AAV.hSyn.Cre.WPRE.hGH (#105553). In addition to the viral particles, you will also receive purified pENN.AAV.hSyn.Cre.WPRE.hGH plasmid DNA. hSyn-driven Cre expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    July 26, 2018
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-hSyn-DIO-mCherry (AAV8)

    Viral Prep
    #50459-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-hSyn-DIO-mCherry (#50459). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-mCherry plasmid DNA. hSyn-driven, Cre-dependent mCherry-expression control. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCherry (Cre-dependent)
    Available Since
    Oct. 3, 2016
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV-Ef1a-DIO EYFP (AAV5)

    Viral Prep
    #27056-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-Ef1a-DIO EYFP (#27056). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO EYFP plasmid DNA. EF1a-driven, cre-dependent EYFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tags
    EYFP (Cre-dependent)
    Available Since
    Feb. 14, 2018
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV_hSyn1-SIO-stGtACR2-FusionRed (AAV5)

    Viral Prep
    #105677-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV_hSyn1-SIO-stGtACR2-FusionRed (#105677). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR2-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    FusionRed (Cre-dependent)
    Available Since
    Oct. 21, 2024
    Availability
    Academic Institutions and Nonprofits only
  7. pAAV_BiCHATe27_GCaMP6f (AAV5)

    Viral Prep
    #213833-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only
  8. pAAV.Syn.GCaMP6f.WPRE.SV40 (AAV5)

    Viral Prep
    #100837-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.Syn.GCaMP6f.WPRE.SV40 (#100837). In addition to the viral particles, you will also receive purified pAAV.Syn.GCaMP6f.WPRE.SV40 plasmid DNA. Syn-driven GCaMP6f calcium sensor. These AAV preparations are suitable purity for injection into animals.
    Promoter
    Syn
    Available Since
    March 19, 2018
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV-hSyn-DIO-hM4D(Gi)-mCherry (AAV8)

    Viral Prep
    #44362-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-hSyn-DIO-hM4D(Gi)-mCherry (#44362). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-hM4D(Gi)-mCherry plasmid DNA. Syn-driven, Cre-dependent, hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    mCherry (Cre-dependent)
    Available Since
    Sept. 28, 2016
    Availability
    Academic Institutions and Nonprofits only
  10. pAAV-GFAP-hM3D(Gq)-mCherry (AAV5)

    Viral Prep
    #50478-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-GFAP-hM3D(Gq)-mCherry (#50478). In addition to the viral particles, you will also receive purified pAAV-GFAP-hM3D(Gq)-mCherry plasmid DNA. GFAP-driven hM4D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GFAP
    Tags
    mCherry
    Available Since
    June 19, 2018
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV-Ef1a-DIO EYFP (AAV1)

    Viral Prep
    #27056-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-Ef1a-DIO EYFP (#27056). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO EYFP plasmid DNA. EF1a-driven, cre-dependent EYFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tags
    EYFP (Cre-dependent)
    Available Since
    March 16, 2018
    Availability
    Academic Institutions and Nonprofits only
  12. pGP-AAV-syn-jGCaMP8m-WPRE (AAV PHP.eB)

    Viral Prep
    #162375-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pGP-AAV-syn-jGCaMP8m-WPRE (#162375). In addition to the viral particles, you will also receive purified pGP-AAV-syn-jGCaMP8m-WPRE plasmid DNA. Syn-driven expression of calcium sensor GCaMP8m (faster, more sensitive). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    June 21, 2024
    Availability
    Academic Institutions and Nonprofits only
  13. AAV-GfaABC1D-Cre-4x6T (AAV5)

    Viral Prep
    #196410-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from AAV-GfaABC1D-Cre-4x6T (#196410). In addition to the viral particles, you will also receive purified AAV-GfaABC1D-Cre-4x6T plasmid DNA. GfaABC1D driven expression of Cre recombinase in astrocytes. These AAV preparations are suitable purity for injection into animals.
    Promoter
    CAG and GfaABC1D
    Available Since
    Sept. 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  14. pAAV-nEF-Coff/Fon-NpHR3.3-EYFP (AAV8)

    Viral Prep
    #137154-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-nEF-Coff/Fon-NpHR3.3-EYFP (#137154). In addition to the viral particles, you will also receive purified pAAV-nEF-Coff/Fon-NpHR3.3-EYFP plasmid DNA. nEF-driven, Flp-dependent expression of NpHR3.3-EYFP (inhibited in presence of Cre) for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Promoter
    nEF
    Tags
    EYFP (Flp-dependent)
    Available Since
    April 8, 2021
    Availability
    Academic Institutions and Nonprofits only
  15. pAAV-mDlx-GFP-Fishell-1 (AAV5)

    Viral Prep
    #83900-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-mDlx-GFP-Fishell-1 (#83900). In addition to the viral particles, you will also receive purified pAAV-mDlx-GFP-Fishell-1 plasmid DNA. mDlx-driven expression of GFP in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    mDlx
    Tags
    GFP
    Available Since
    Aug. 25, 2023
    Availability
    Academic Institutions and Nonprofits only
  16. pAAV.TBG.PI.eGFP.WPRE.bGH (AAV8)

    Viral Prep
    #105535-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV.TBG.PI.eGFP.WPRE.bGH (#105535). In addition to the viral particles, you will also receive purified pAAV.TBG.PI.eGFP.WPRE.bGH plasmid DNA. TBG-driven eGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    TBG
    Tags
    EGFP
    Available Since
    April 30, 2018
    Availability
    Academic Institutions and Nonprofits only
  17. pAAV-CAG-tdTomato (codon diversified) (AAV Retrograde)

    Viral Prep
    #59462-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-CAG-tdTomato (codon diversified) (#59462). In addition to the viral particles, you will also receive purified pAAV-CAG-tdTomato (codon diversified) plasmid DNA. tdTomato expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    tdTomato (codon diversified)
    Available Since
    May 10, 2017
    Availability
    Academic Institutions and Nonprofits only
  18. pZac2.1-GfaABC1D-lck-jGCaMP8f (AAV9)

    Viral Prep
    #176759-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pZac2.1-GfaABC1D-lck-jGCaMP8f (#176759). In addition to the viral particles, you will also receive purified pZac2.1-GfaABC1D-lck-jGCaMP8f plasmid DNA. GfaABC1D-driven expression of membrane-bound calcium sensor GCaMP8f. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    GfaABC1D
    Available Since
    Feb. 24, 2023
    Availability
    Academic Institutions and Nonprofits only
  19. pENN.AAV.CamKII.GCaMP6f.WPRE.SV40 (AAV1)

    Viral Prep
    #100834-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pENN.AAV.CamKII.GCaMP6f.WPRE.SV40 (#100834). In addition to the viral particles, you will also receive purified pENN.AAV.CamKII.GCaMP6f.WPRE.SV40 plasmid DNA. CamKII-driven GCaMP6f calcium sensor. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CaMKII
    Available Since
    May 3, 2018
    Availability
    Academic Institutions and Nonprofits only
  20. pAAV-EF1a-Cre (AAV Retrograde)

    Viral Prep
    #55636-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-EF1a-Cre (#55636). In addition to the viral particles, you will also receive purified pAAV-EF1a-Cre plasmid DNA. EF1a-driven expression of Cre recombinase. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Nov. 12, 2020
    Availability
    Academic Institutions and Nonprofits only
Showing: 21 - 40 of 1077 results